These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. Lipkovich IA; Deberdt W; Csernansky JG; Sabbe B; Keefe RS; Kollack-Walker S BMC Psychiatry; 2009 Jul; 9():44. PubMed ID: 19602273 [TBL] [Abstract][Full Text] [Related]
5. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Couture SM; Granholm EL; Fish SC Schizophr Res; 2011 Feb; 125(2-3):152-60. PubMed ID: 20965699 [TBL] [Abstract][Full Text] [Related]
6. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Bowie CR; Reichenberg A; Patterson TL; Heaton RK; Harvey PD Am J Psychiatry; 2006 Mar; 163(3):418-25. PubMed ID: 16513862 [TBL] [Abstract][Full Text] [Related]
7. Social cognitive markers of short-term clinical outcome in first-episode psychosis. Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633 [TBL] [Abstract][Full Text] [Related]
8. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863 [TBL] [Abstract][Full Text] [Related]
9. A social path to functioning in schizophrenia: From social self-efficacy through negative symptoms to social functional capacity. Vaskinn A; Ventura J; Andreassen OA; Melle I; Sundet K Psychiatry Res; 2015 Aug; 228(3):803-7. PubMed ID: 26089018 [TBL] [Abstract][Full Text] [Related]
10. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Bowie CR; Depp C; McGrath JA; Wolyniec P; Mausbach BT; Thornquist MH; Luke J; Patterson TL; Harvey PD; Pulver AE Am J Psychiatry; 2010 Sep; 167(9):1116-24. PubMed ID: 20478878 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia. González-Blanch C; Perez-Iglesias R; Pardo-García G; Rodríguez-Sánchez JM; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B Psychol Med; 2010 Jun; 40(6):935-44. PubMed ID: 19751542 [TBL] [Abstract][Full Text] [Related]
12. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Brekke JS; Hoe M; Long J; Green MF Schizophr Bull; 2007 Sep; 33(5):1247-56. PubMed ID: 17255120 [TBL] [Abstract][Full Text] [Related]
13. Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity. Strassnig MT; Raykov T; O'Gorman C; Bowie CR; Sabbag S; Durand D; Patterson TL; Pinkham A; Penn DL; Harvey PD Schizophr Res; 2015 Jun; 165(1):76-82. PubMed ID: 25868935 [TBL] [Abstract][Full Text] [Related]
14. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia. Lin CH; Huang CL; Chang YC; Chen PW; Lin CY; Tsai GE; Lane HY Schizophr Res; 2013 May; 146(1-3):231-7. PubMed ID: 23478155 [TBL] [Abstract][Full Text] [Related]
15. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765 [TBL] [Abstract][Full Text] [Related]
17. Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Smith TE; Hull JW; Israel LM; Willson DF Schizophr Bull; 2000; 26(1):193-200. PubMed ID: 10755681 [TBL] [Abstract][Full Text] [Related]
18. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome. Fervaha G; Foussias G; Agid O; Remington G Schizophr Res; 2015 Aug; 166(1-3):9-16. PubMed ID: 25982811 [TBL] [Abstract][Full Text] [Related]
19. Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Velligan DI; Bow-Thomas CC; Mahurin RK; Miller AL; Halgunseth LC J Nerv Ment Dis; 2000 Aug; 188(8):518-24. PubMed ID: 10972571 [TBL] [Abstract][Full Text] [Related]
20. Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia. Penadés R; Boget T; Catalán R; Bernardo M; Gastó C; Salamero M Schizophr Res; 2003 Oct; 63(3):219-27. PubMed ID: 12957701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]